A PK Study of IkT-148009 in Older and Elderly Healthy Subjects

NCT06644326 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: 100mg IkT-148009 Wet
DRUG: 200 mg Itraconazole
DRUG: 100mg IkT-148009 Dry
DRUG: 50mg IkT-148009 Wet

Sponsor

ABLi Therapeutics, Inc.